PTX 4.76% 4.4¢ prescient therapeutics limited

Starry syndicate powers $165M bet on in vivo CAR-T therapies, enabling Penn spinout Capstan to set sail, page-7

  1. 667 Posts.
    lightbulb Created with Sketch. 58
    It killed the cancer cells...The cells were washed & rested with a break in binder... The cells were reactivated days later via re-administering of binder and continued to aggressively kill the cancer cells...I think they even tried multiple tags but were contemplating testing just how many different tags they could use simultaneously next test aimed at different cancer proteins because as we know, one of the biggest limitations of current CAR-T is not being able to attack multiple cancer cells that can quickly mutate...OmniCAR clinician simply adds another binder aimed at the new mutation on the spot and we are cooking with gas.

    this is the spine tingling bit of the whole story
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.4¢
Change
0.002(4.76%)
Mkt cap ! $35.43M
Open High Low Value Volume
4.2¢ 4.5¢ 4.0¢ $86.80K 2.053M

Buyers (Bids)

No. Vol. Price($)
1 141 4.3¢
 

Sellers (Offers)

Price($) Vol. No.
4.5¢ 27067 1
View Market Depth
Last trade - 13.58pm 14/06/2024 (20 minute delay) ?
Last
4.4¢
  Change
0.002 ( 4.76 %)
Open High Low Volume
4.2¢ 4.5¢ 4.0¢ 1473099
Last updated 13.58pm 14/06/2024 ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.